COVID-19 Update: Vaccine notifications will go through MyScripps and email — please do not call your doctor. Learn more.

35th Annual New Treatments in Chronic Liver Disease

A banner for this June 2021 conference shows five small images of shorelines in San Diego.

Join us June 26-27, 2021 for this live streaming virtual CME event!

This course is a comprehensive yet concise program for updating physicians on commonly encountered problems in the treatment of liver diseases.

Conference Details

Course Overview

This CME conference will review new medications and therapies that are now available, or will soon be available, and discuss their comparative values. The results of trials and real-world data using oral drugs to treat chronic viral hepatitis B and C, non-alcoholic fatty liver diseases, primary biliary cirrhosis, primary sclerosing cholangitis, hepatocellular carcinoma and complications of end-stage liver disease including thrombocytopenia will be reviewed in detail. New Treatments in Chronic Liver Disease is a comprehensive yet concise program for updating physicians on these and other commonly encountered problems in the treatment of liver diseases.

Educational Objectives

After attending this live internet activity, participants should be able to:

  • Identify the steps required to accomplish eradication of chronic viral hepatitis by 2030.
  • Review current knowledge of NAFLD and non-alcoholic steatohepatitis and explore the use of new agents and approaches to treatment of the conditions.
  • Integrate the algorithm for a therapeutic approach to treatment of HBV using anti-virals.
  • Discuss diagnosis, management and treatment unusual hepatitis virus infections.
  • Update the skills and management required for transplant hepatology.
  • Apply current options of therapy for hepatocellular carcinoma to determine the best approach for your patients.
  • Describe the diagnosis and treatment of PBC and PSC.
  • Integrate treatment options discussed for patients with ESLD due to alcohol who have complicating factors such as HCV, NASH or inherited genetic disorders.
  • Discuss the issues complicating drug treatment in decompensated cirrhosis, hepatic encephalopathy and hyponatremia.
  • Update the diagnosis and management benign masses in the liver.
  • Discuss the rising burden of alcoholic liver disease in the United States.
  • Discuss advances in treatment of acute liver failure.

Accreditation and Disclosures

Physicians

Scripps Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 


ABIM MOC Points

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.


Nurses and Nurse Practitioners

For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit(s)™ issued by organizations accredited by the ACCME.


For the purpose of re-licensure, the California Board of Registered Nursing accepts AMA PRA Category 1 Credit(s)™ for attendance at structured learning activities offered by organizations accredited by the ACCME.


The American Academy of Nurse Practitioners Certified Program (AANPCP) and the American Association of Nurse Practitioners (AANP) accept AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.


Physician Assistants

PAs may claim Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.


Commercial Support

This course is supported, in part, by educational grants from industry, in accordance with ACCME Accreditation Standards for Commercial Support. Appropriate acknowledgment will be given to all supporters at the time of the educational activity.


Cultural and Linguistic Competency

This activity is in compliance with California Assembly Bill 1195, which requires that all CME activities comprising a patient care element include curriculum addressing the topic of cultural and linguistic competency. The intent of this bill is to ensure that health care professionals are able to meet the cultural and linguistic concerns of a diverse patient population through effective and appropriate professional development. The planners, speakers and authors of this CME activity have been encouraged to address issues relevant in their topic area. A variety of resources are available that address cultural and linguistic competency, some of which can be found in the Cultural & Linguistic Competency Resource Guide.

Event details

Date and time
Sat, Jun 26, 2021 at 7 am to

Sun, Jun 27, 2021 at 11:45 am